江中药业：8月20日召开董事会会议

Group 1 - Jiangzhong Pharmaceutical (SH 600750) announced on August 21 that its 10th Board of Directors held a meeting on August 20, 2025, to review the proposal for the reappointment of the auditing institution for the fiscal year 2025 [1] - For the first half of 2025, Jiangzhong Pharmaceutical's revenue composition was as follows: pharmaceutical industry accounted for 99.64%, liquor industry accounted for 0.25%, and other businesses accounted for 0.11% [1] - As of the time of reporting, Jiangzhong Pharmaceutical had a market capitalization of 14.2 billion yuan [1]